UBS raised the firm’s price target on Ibotta (IBTA) to $55 from $42 and keeps a Neutral rating on the shares. Strategic supply and demand initiatives are showing early progress, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBTA:
- Ibotta price target raised to $60 from $52 at Wells Fargo
- Ibotta, Inc.’s Strategic Shift to CPID Model Fuels Buy Rating and Promises Future Growth
- Ibotta, Inc. Reports Modest Revenue Growth in Q1 2025
- Closing Bell Movers: Foot Locker up nearly 70% on Dick’s buyout
- Ibotta reports Q1 adjusted EPS 36c vs 53c last year